Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO ...

Heartflow (NASDAQ:HTFL), a MedTech firm backed by private equity firms including Bain Capital, climbed ~50% on its first ...

Bain Capital Specialty Finance delivered a strong Q2, reinforcing its value, dividend safety, and limited downside risk. Read ...

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable ...

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

Bain Capital Specialty Finance, Inc. (BCSF) Q2 2025 Management View CEO Michael Alexander Ewald highlighted "Q2 net investment income per share was $0.47, representing an annualized yield on book ...

On a per-share basis, the Boston-based company said it had profit of 37 cents. Earnings, adjusted for investment costs, were ...

Pharma is looking for fewer, scaled providers at an enterprise level to reduce risk and provide a better-integrated service,' ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five ...

Bain Capital and 11North Partners paid $395 million for a portfolio of 10 shopping centers in Florida and South Carolina, ...

A joint venture between Bain Capital and 11North Partners has purchased a portfolio of 10 open-air retail centers in Florida ...